T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Equifax
EFX
|
$760M |
| 2 |
Xcel Energy
XEL
|
$577M |
| 3 |
Linde
LIN
|
$572M |
| 4 |
Intercontinental Exchange
ICE
|
$549M |
| 5 |
AbbVie
ABBV
|
$530M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$948M |
| 2 |
TE Connectivity
TEL
|
$731M |
| 3 |
Yum! Brands
YUM
|
$724M |
| 4 |
Becton Dickinson
BDX
|
$718M |
| 5 |
Ingersoll Rand
IR
|
$664M |
Sector Composition
| 1 | Technology | 23.66% |
| 2 | Healthcare | 22.34% |
| 3 | Financials | 13.96% |
| 4 | Industrials | 11.89% |
| 5 | Consumer Discretionary | 11.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
O'Reilly Automotive
ORLY
$88B
| $510M | 0.39% | 604,022 -101,581 | -14% | -$85.7M |
|
77
Verisk Analytics
VRSK
$37.5B
| $499M | 0.38% | 2,827,459 +2,364 | +0.1% | +$417K |
|
78
Five Below
FIVE
$8B
| $483M | 0.37% | 2,730,378 +259,012 | +10% | +$45.8M |
|
79
Tradeweb Markets
TW
$26.3B
| $475M | 0.36% | 7,322,321 +4,873 | +0.1% | +$316K |
|
80
argenx
ARGX
$43.6B
| $465M | 0.36% | 1,226,867 -791,351 | -39% | -$300M |
|
|
HZNP
81
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $461M | 0.35% | +4,050,259 | New | +$461M |
|
82
IDEX
IEX
$12.4B
| $461M | 0.35% | 2,018,566 +440 | +0% | +$100K |
|
83
Visa
V
$683B
| $453M | 0.35% | 2,180,527 -164,314 | -7% | -$34.1M |
|
84
Eli Lilly
LLY
$657B
| $446M | 0.34% | +1,218,959 | New | +$446M |
|
85
PTC
PTC
$25.6B
| $443M | 0.34% | 3,691,102 +4,760 | +0.1% | +$571K |
|
86
Ionis Pharmaceuticals
IONS
$6.79B
| $441M | 0.34% | 11,678,259 +521,564 | +5% | +$19.7M |
|
87
Alcon
ALC
$39.5B
| $436M | 0.33% | 6,364,199 +13,120 | +0.2% | +$899K |
|
88
NVIDIA
NVDA
$4.24T
| $435M | 0.33% | 2,977,314 +688,886 | +30% | +$101M |
|
89
RPM International
RPM
$16.1B
| $430M | 0.33% | 4,414,175 -1,024,663 | -19% | -$99.9M |
|
90
Amphenol
APH
$133B
| $420M | 0.32% | 5,518,528 +2,992 | +0.1% | +$228K |
|
91
Exelon
EXC
$44.1B
| $413M | 0.32% | +9,559,548 | New | +$413M |
|
92
Boston Beer
SAM
$2.41B
| $408M | 0.31% | 1,239,545 -132,519 | -10% | -$43.7M |
|
93
West Pharmaceutical
WST
$17.8B
| $405M | 0.31% | 1,719,972 +12,228 | +0.7% | +$2.88M |
|
94
ESAB
ESAB
$7B
| $400M | 0.31% | 8,517,838 +1,920,386 | +29% | +$90.1M |
|
95
CrowdStrike
CRWD
$106B
| $396M | 0.3% | 3,761,214 +1,440,905 | +62% | +$152M |
|
96
ICU Medical
ICUI
$3.15B
| $382M | 0.29% | 2,423,228 -55,633 | -2% | -$8.76M |
|
97
GE HealthCare
GEHC
$33.7B
| $378M | 0.29% | +6,480,940 | New | +$378M |
|
98
Magnolia Oil & Gas
MGY
$4.61B
| $369M | 0.28% | 15,720,703 +55,508 | +0.4% | +$1.3M |
|
99
Starbucks
SBUX
$100B
| $367M | 0.28% | 3,699,200 -2,373,024 | -39% | -$235M |
|
100
Cheniere Energy
LNG
$53.1B
| $364M | 0.28% | 2,427,260 -599,269 | -20% | -$89.9M |
|